Edwards Lifesciences Corporation Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount
Edwards Lifesciences Corporation (EW) reported Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount of $31.30 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCreditsResearch · last filed 2026-02-25
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2013-12-31 was $0.00.
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2013-09-30 was $0.00.
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2013-06-30 was $0.00.
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, research, amount for the quarter ending 2013-03-31 was $8.40M.
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, research, amount for fiscal 2025 was $31.30M.
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, research, amount for fiscal 2013 was $8.40M, a 71.43% increase from fiscal 2012.
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, research, amount for fiscal 2012 was $4.90M, a 52.88% decline from fiscal 2011.
- Edwards Lifesciences Corporation effective income tax rate reconciliation, tax credit, research, amount for fiscal 2011 was $10.40M, a 33.33% increase from fiscal 2010.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 9 month | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | $31.30M 10-K · filed 2026-02-25 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $0.00 derived: sum of 2 quarters · filed 2016-02-19 | $0.00 derived: sum of 3 quarters · filed 2016-02-19 | $8.40M 10-K · filed 2016-02-19 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | $0.00 derived: sum of 2 quarters · filed 2014-10-31 | $8.40M 10-Q · filed 2014-10-31 | |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $8.40M 10-Q · filed 2014-08-04 | ||
| 2013-03-31 | $8.40M 10-Q · filed 2014-05-02 | |||
| 2012-12-31 | $4.90M 10-K · filed 2013-02-28 | |||
| 2011-12-31 | $10.40M 10-K · filed 2013-02-28 | |||
| 2010-12-31 | $7.80M 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $5.50M 10-K · filed 2012-02-27 | |||
| 2008-12-31 | $3.50M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |